公开(公告)号：US06444819B1

公开(公告)日：2002-09-03

申请号：US09975535

申请日：2001-10-11

申请人： Renata Xavier Kover ,  Salva Terdjanian ,  Jennifer Tran ,  Andrew Thurkauf

发明人： Renata Xavier Kover ,  Salva Terdjanian ,  Jennifer Tran ,  Andrew Thurkauf

IPC分类号： C07D22120

CPC分类号： C07D295/15 ,  C07D209/08 ,  C07D401/06

摘要： Disclosed are compounds of the formula: or pharmaceutically acceptable addition salts thereof wherein: Y represents oxygen or sulfur; Z is nitrogen or CH; R1, R2 and R3 independently represent organic or inorganic substituents; R4 and R4′ independently represent hydrogen, alkyl or form a ring with the atom to which they are attached; R5 represents hydrogen, alkyl, alkoxy, or alkylthio, and R6 represents hydrogen or alkyl; or R5 and R6 form a ring together with the atoms to which they are attached; and R7, R8, R9, R10, and R11 independently represent hydrogen or alkyl, which compounds are useful for the treatment and/or prevention of neuropsychological disorders including, but not limited to, schizophrenia, mania, dementia, depression, anxiety, compulsive behavior, substance abuse, Parkinson-like motor disorders and motion disorders related to the use of neuroleptic agents.

摘要翻译： 公开了下式的化合物或其药学上可接受的加成盐，其中：Y表示氧或硫; Z是氮或CH; R 1，R 2和R 3独立地表示有机或无机取代基; R 4和R 4'独立地表示氢，烷基或与它们连接的原子形成环; R 5表示氢，烷基，烷氧基或烷硫基 ，R6代表氢或烷基; 或R 5和R 6与它们所连接的原子一起形成环; 和R 7，R 8，R 9，R 10和R 11独立地表示氢或烷基，该化合物可用于治疗和/或预防神经心理障碍，包括但不限于精神分裂症，躁狂症，痴呆，抑郁症，焦虑症，强迫行为， 药物滥用，帕金森样运动障碍和与使用精神安定药有关的运动障碍。